New synthesis of (E,Z)-2,7-bis(4-cyanobenzylidene)cycloheptan-1-one under stereospecific constraints induced by host-guest interactions

Grandeury, A.; Petit, P.; Coste, S.; Coquerel, G.; Perrio, C.; Gouhier, G.

Chem. Commun. 2005, 4007-4009


Synthesis of  2-substituted β-cyclodextrins derivatives with a hydrolytic activity against the organophosphorylester paraoxon.

Masurier N, Estour F, Froment MT, Lefèvre B, Debouzy JC, Brasme B, Masson P, Lafont O.

Eur. J. Med. Chem. 2005, 40(7), 615-623.


Improved access to 2-O-monobenzyl ethers of β-cyclodextrin as precursors of catalysts for organophosphoryl esters hydrolysis.

Masurier N., Estour F., Lefèvre B., Brasme B., Masson P., Lafont O.

Carbohydr. Res., 2006, 341, 935-940.


Chiral discrimination in host-guest supramolecular complexes. Understanding enantioselectivity and solid solution behaviours by using spectroscopic methods and chemical sensors.

Grandeury, A.; Condamine, E.; Hilfert, L.; Gouhier, G.; Petit, S.; Coquerel, G.

J. Phys. Chem. B. 2007, 111, 7017-7026


Regioselective access to 3I-O-substituted-β-cyclodextrin derivatives.

Masurier N., Lafont O., Le Provost R., Lesur D., Masson P., Djedaïni-Pilard F., Estour F.

Chem. Commun., 2009, 589-591.


Detoxification of nerve agents by a substituted β-cyclodextrin: Application of a modified biological assay.

Wille T., Tenberken O., Reiter G., Müller S., Le Provost R., Lafont O., Estour F., Thiermann H., Worek F.

Toxicology, 2009, 96-100.


Smart contrast agents for MRI imaging.

Gouhier, G.; Estour F.;

2009, PCT/EP2009/067587


In vitro detoxification of cyclosarin (GF) by modified cyclodextrins.

Müller S, Kollera M, Le Provost R., Lafont O., Estour F., Wille T., Thiermann H., Worek F., Reiter G.

Toxicol. Lett., 2011, 200, 53-58.


Optimized strategies to synthesize β-cyclodextrin-oxime conjugates as a new generation of organophosphate scavengers.

Le Provost R., Wille T., Louise L., Masurier N., Müller S., Reiter G., Renard P.Y., Lafont O., Worek F., Estour F.

Org. Biomol. Chem., 2011, 9, 3026-3032.